WAINUA 45 mg/.8mL
EPLONTERSEN · INJECTION, SOLUTION · AstraZeneca Pharmaceuticals LP
No Recall History
Plain English
WAINUA is a injection, solution containing eplontersen at 45 mg/.8mL, taken subcutaneous. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- WAINUA
- Generic Name
- EPLONTERSEN
- NDC Code (Product)
0310-9420- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 45 mg/.8mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA217388
- Drug Class
- Transthyretin-directed RNA Interaction [EPC]; Antisense Oligonucleotide [EPC]
- Marketing Start
- 04/30/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is WAINUA used for?
WAINUA contains EPLONTERSEN. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is WAINUA a controlled substance?
WAINUA is not classified as a controlled substance by the DEA.
What is the generic name for WAINUA?
The generic name for WAINUA is EPLONTERSEN. There are no other listed brand versions of EPLONTERSEN.
What is the NDC code for WAINUA 45 mg/.8mL?
The NDC (National Drug Code) for WAINUA 45 mg/.8mL is 0310-9420, listed by AstraZeneca Pharmaceuticals LP.
Other WAINUA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)